115 results
8-K
EX-10.2
INBS
Intelligent Bio Solutions Inc
22 Dec 22
Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering
5:28pm
such Indemnified Party of such claim or proceeding, to assume, at the Indemnifying Party’s expense, the defense of any such claim or litigation … to employ separate counsel in any such claim or litigation, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party
8-K
EX-10.2
INBS
Intelligent Bio Solutions Inc
11 Oct 22
GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
6:07am
expense, the defense of any such claim or litigation, with counsel reasonably satisfactory to the Indemnified Party and, after notice from … , however, that an Indemnified Party shall have the right to employ separate counsel in any such claim or litigation, but the fees and expenses
8-K
EX-10.3
INBS
Intelligent Bio Solutions Inc
11 Oct 22
GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
6:07am
such Indemnified Party of such claim or proceeding, to assume, at the Indemnifying Party’s expense, the defense of any such claim or litigation … to employ separate counsel in any such claim or litigation, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
21 Jun 23
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
2:30pm
and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without
UPLOAD
g9m0yr374
16 Aug 19
Letter from SEC
12:00am
8-K
EX-99.1
9wrm wxrhso0r0
21 Dec 22
Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders
4:48pm
8-K
EX-99.1
ebtirdtr4btrx
20 Feb 24
Other Events
5:05pm
8-K
EX-99.1
3izzj
17 May 23
Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
4:15pm
424B3
z8pyo3 1q
10 Jul 23
Prospectus supplement
5:11pm
8-K
EX-99.1
t9lai4hmflfwzs
26 Jan 24
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
5:05pm
8-K
EX-99.1
0v0zaaidcox64wej
12 Apr 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
dxoad7obu
1 Dec 21
GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study
4:05pm
8-K
EX-99.1
h8u01c4eati
16 Dec 21
GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
4:05pm
8-K
EX-99.1
4b0v8wr8xarok9mnc
1 Aug 23
Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia
5:00pm
8-K
EX-99.1
ewmu4c9x
1 Apr 22
GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center
9:30am
8-K
EX-99.1
d3az1ty
14 Oct 21
GBS Inc. Announces its Pre-Submission package is with the FDA
12:00pm
8-K
EX-99.1
ok0cl eq7fwjza
22 Dec 22
Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering
5:28pm
CORRESP
hkf hz07peazztudfd
21 Aug 19
Correspondence with SEC
12:00am